Publications

Book/Book Chapters

  • Book: Micro- and Nanotechnologies Based Sterile Product Development. Editors: Dr. Neelsh Kumar Mehra and Dr. Arvind Gulbake, 2021, Publisher: CRC Press, Taylor & Francis Group, LLC., ISBN 9780367488451

  • “Bentley’s: Text Book of Pharmaceutics” An Adoptation: edited by Jain SK & Soni V. original editor E. A. Rawlin, Chapter title “New Drug Delivery Systems” Gulbake A, Soni V & Jain SK. 2011, Published by Elsevier India Pvt. Ldt. New Delhi.

  • “Chitosan: Manufacture, properties, and usage” edited by Davis SP. Chapter title “Chitosan: A Potential Bio-Polymer for Drug Delivery” Jain SK, Khare P, Gulbake A & Shilpi S. 2010, Published by NOVA Science Publisher. ISBN: 978-1-61761-051-6.

  • “Oral Modified Release Drug Delivery Systems” Editors: Piush Khare, Mohini Chaurasia, Sarvesh K. Paliwal. Chapter title “Colon Specific Drug Delivery Systems” Gulbake A, Kumar P, Khare P, Jain N.K. 2016, Pharmamed Press, Hyderabad. ISBN No. 9789352301010.

  • “Functional Hydrogels in drug delivery: Key features and future prospective” Chapter title “Prodrugs and Bioconjugate Hydrogels: A Valuable Strategy for the Prolonged-Delivery of Drugs” Jain A, Sahu A, Jain A, Gulbake A. 2017, Science Publisher in cooperation with CRC press. ISBN-97814 9874 9015.

Peer-Reviewed National/International Publications
(Google Scholar Citations>1195 & h-index:19; Scopus Citations>856 & h-index:19)

1. Gulbake A, Jain A, Khare P & Jain SK. (2010). Solid lipid nanoparticles bearing oxybenzone: In vitro in vivo evaluation. J Microencap. 27(3):226-33. (IF= 1.793)

2. Mishra P, Gulbake A, Jain A, Khare P, Soni V, Vyas SP & Jain SK. (2009). Steroid receptors as molecular targets for cancer diagnosis and therapy. Cri Rev Ther Drug Carrier Sys. 26(3):207-73. (IF= 3.32)

3. Mishra P, Gulbake A, Jain A, Vyas SP & Jain SK. (2009). Targeted delivery of an anti-cancer agent via steroid coupled liposomes. Drug Del. 16(8):437-47. (IF= 6.402)

4. Khare P, Jain A, Gulbake A, Soni V, Jain NK & Jain SK. (2009). Bioconjugates: Harnessing potential for effective therapeutics. Cri Rev Ther Drug Carrier Sys. 26(2):119-55. (IF= 3.32)

5. Bagari R, Bansal D, Gulbake A, Jain A, Soni V & Jain SK. (2011). Chondroitin sulfate functionalized liposomes for solid tumor targeting. J Drug Targ. 19(4):251-57. (IF= 3.408)

6. Jain S, Jain S, Khare P, Gulbake A, Bansal D & Jain SK. (2010). Design and development of solid lipid nanoparticles for topical delivery of an anti-fungal agent. Drug Del. 17, (6): 443-51. (IF= 6.402)

7. Soni V, Jain A, Khare P, Gulbake A & Jain SK. (2010) Potential approaches for drug delivery to the brain: Past, present, and future. Cri Rev Ther Drug Carrier Sys. 27(3):187-236. (IF= 3.32)

8. Jain SK, Jain A, Gulbake A, Shilpi S & Khare P. (2010). Steroid Coupled liposomes for targeted delivery to tumor. Ther Del. Future Science Group. 1(2): 345-357. (Scopus)

9. Rathore A, Jain A, Gulbake A, Shilpi S, Khare P, Jain A & Jain SK. (2010). Mannosylated liposomes bearing amphotericin B for effective management of visceral leishmaniasis. J Lipo Res. 21(4):333-40. (IF= 2.576)

10. Mahalwar A, Gulbake A, Jain A, Shilpi S, Sharma B, Joshi B & Jain SK. (2012). Evaluation of Effect of Ligand on Cellular Internalization: a Comparative Study of Nanoparticles and Multifunctional Nanoparticles on MDA-MB-231 Cells. Curr Nanosci. 8(3): 432-40. (IF= 1.306)

11. Jain A, Gulbake A, Jain A, Shilpi S, Hurkat P, Jain A & Jain SK. (2012). Development of surface-functionalised nanoparticles for FGF2 receptor-based solid tumor targeting. J Microencap. 29(1): 95-102. (IF= 1.793)

12. Jain A, Jain A, Gulbake A, Hurkat P & Jain SK. (2011). Solid tumors: A review. Int J Phar Pharm Sci. 3(5): 45-51.

13. Kumar P, Gulbake A & Jain SK. (2012). Liposomes a vesicular nanocarrier: Potential advancements in cancer chemotherapy. Cri Rev Ther Drug Carrier Sys. 29(5) 355-419. (IF= 3.32)

14. Gulbake A & Jain SK. (2012). Chitosan: A potential polymer for colon-specific drug delivery system. Exp Opin Drug Del. 9(6): 713-729. (IF= 5.6)

15. Hurkat P, Jain A, Jain A, Shilpi S, Gulbake A & Jain SK. (2012). Concanavalin A conjugated biodegradable nanoparticles for oral insulin delivery. J Nano Res. 14(11): 1-14. (IF= 2.18)

16. Gulbake A, Jain A & Jain SK. (2012). Development of nanostructured lipid carrier as potential sun protectant. Nanosci & Nanotech-Asia. 2:210-216.

17. Jain A, Gulbake A, Shilpi S, Jain A, Hurkat P & Jain SK. (2013). A new horizon in modifications of chitosan: Syntheses and applications. Cri Rev Ther Drug Carrier Sys. 30(2): 91–181. (IF= 3.32)

18. Nema T, Jain A, Jain A, Shilpi S, Gulbake A, Hurkat P & Jain SK. (2013). Insulin delivery through nasal route using thiolated microspheres. Drug Del. 20(5): 210-215. (IF= 6.402)

19. Jain A, Jain A, Gulbake A, Shilpi S, Hurkat P & Jain SK. (2013). Peptide and protein delivery using new drug delivery systems. Cri Rev Ther Drug Carrier Sys. 30(4): 293–329. (IF= 3.32)

20. Jain A, Gulbake A, Shilpi S, Jain A, Hurkat P & Jain SK. (2013). Dual drug delivery using "smart" liposomes for triggered Release of anticancer agents. J Nanoparticle Res. 15(7): 1-12. (IF= 2.18)

21. Jain A, Gulbake A, Jain A, Shilpi S, Hurkat P, Kashaw S & Jain SK. (2013). Development and validation of HPLC method for simultaneous estimation of Paclitaxel and Topotecan, J Chrom Sci. 52(7): 697-703. (IF= 1.169)

22. Kharya P, Jain A, Gulbake A, Shilpi S, Jain A, Hurkat P, Majumdar S & Jain SK. (2013). Phenylalanine coupled solid lipid nanoparticles for brain tumor targeting. J Nanoparticle Res. 15(11): 1-12. (IF= 2.18)

23. Dangi R, Hurkat P, Jain A, Shilpi S, Jain A, Gulbake A, Jain SK. (2014). Targeting liver cancer via ASGP receptor using 5-Fu loaded surface modified PLGA nanoparticles. J Microencap. 31 (5): 479-487. (IF= 1.793)

24. Shrivastava M., Jain A, Gulbake A, Hurkat P, Jain N, Vijayraghwan R., Jain S.K. (2014). Low Density Lipid Nanoparticles for Solid Tumor Targeting. Sci Pharm. 82: 873–888. (IF= 0.86)

25. Sahu A., Jain A., Gulbake A. (2014). Colon as Target for Drug Delivery. Current Drug Therapy. 9: 63-73.

26. Subudhi M.B., Jain A, Jain A, Hurkat P, Shilpi S, Gulbake A. and Jain SK. (2015). Eudragit S100 Coated Citrus Pectin Nanoparticles for Colon Targeting of 5-Fluorouracil. Materials. 8: 832-849. (IF= 2.651)

27. Bansal D, Gulbake A, Tiwari J, Jain SK. (2016). Development of liposomes entrapped in alginate beads for the treatment of colorectal cancer. Int J Biol Macromol. 82: 687-695. (IF= 3.909)

28. Gulbake A, Jain A, Jain A, Jain A and Jain SK. (2016) Insight to drug delivery aspects for colorectal cancer. World J Gastroenterology. 22(2): 582-599. (IF= 3.365)

29. Gulbake A, Gupta PN, Gausia C, Sharma P, Saxena A and Jain SK. (2016) Polymeric nanocomposite: development, characterization, ex vivo and in vivo evaluation for ulcerative colitis. Int J Poly Mat. & Poly Biomat. 65 (7): 337-350. (IF= 3.568)

30. Dhumale S B, Sharma S, Gulbake A. (2017) Ano-Genital Warts and HIV Status– A Clinical Study. Journal of Clinical and Diagnostic Research. 11(1): WC01-WC04. (Scopus)

31. Sahu A, Jain A, Gulbake A. (2017) The Role of Carbon Nanotubes in Nanobiomedicines. Int J Pharmacy and Pharma Sci. (Conf Proc.). 9(6), 235-51.

32. Bhatt A, Gurnany E, Modi A, Gulbake A, Jain A. (2017) Theranostic Potential of Targeted Nanoparticles for Brain Cancer. Mini Rev Med Chem. 17, 18, 1758-1777. (IF= 2.903)

33. Sahu Gulbake A, Jain A, Shilpi S, Kumar P, Gulbake A. (2019) Mannosylated Multiwalled Carbon Nanotubes Assisted Artesunate Delivery for Cerebral Malaria. Int J App Pharm. 11, Special Issue 2, 24-30.

34. Momin T, Harugale S, Sahu Gulbake A, Gulbake A. (2019) Recent trends in siRNA delivery for treatment of colorectal cancer. Int J App Pharm. 11, Special Issue 2, 31-36.

35. Patake V. D., Ghogare T. T., Gulbake A. D., Lokhande C. D. (2019) The electrochemical performance of electrodeposited chitosan bio-nanopolymer in non-aqueous electrolyte: a new anodic material for supercapacitor. SN Applied Sciences (Springer Nature), 1:1063.

36. Joshi M.G., Gulbake A, Kashte S.B., Borude P., Apte U., Holgersson S. S. (2019) Xenobiotic-Induced Fetal Hepatocyte Maturation. Applied In Vitro Toxicology, 5 (4), 180-86.

37. Chauhan A., Ranjan R., Avti P., Gulbake A. (2020) Tailoring the nanoparticles surface for efficient cancer therapeutics. Int J App Pharm, 12, Special Issue 4, 11-17

38. Momin T., Gulbake A. (2020) Development and characterization of doxorubicin and siRNA encapsulated chitosan nanoparticles. Int J App Pharm, 12, Special Issue 4, 53-56.

39. Kashte S., Gulbake A., El‑Amin III S.F., Gupta A. (2021) COVID‑19 vaccines: rapid development, implications, challenges and future prospects. Human Cells, 34, 1-23 DOI: 10.1007/s13577-021-00512-4. (IF=3.46)

40. Tiwari R, Sethiya N.K., Gulbake A.S., Mehra N.K., Murty U.S.N., Gulbake A. (2021) A review on albumin as a biomaterial for ocular drug delivery. Int J Bio Macr, 191, 591-599. (IF=6.95)